O2 Investment Partners Announces Appointment of Charlie Miller and Promotion of Joe Vallee and Sean Darin
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
LLR Partners Invests in Supply Chain Management Software Leader Magaya
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Sirnaomics Closes $47 Million Series C Financing to Develop RNAi Therapeutics for Treatment of Cancer and Fibrotic Diseases
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
AskNicely Raises $10M to Power the World’s Best Customer Experiences
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Babel Health Secures $5M Series-A Funding in Partnership with Draper Triangle Ventures and Strategic Healthcare Investor
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
QTC Care Closes 7 million USD Series-A Financing – Focusing on Introducing Global Top Medical Resources to China and Advancing Health Management Platforms
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Lattice raises $15m to help People Leaders develop engaged and high-performing teams
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
AV8 Ventures Launches With $170M to Invest in Digital Health, Mobility and Enterprise Tech
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Talaris Therapeutics, Inc. Announces $100M Series A Financing to Advance Its Novel, Allogeneic Cell Therapy Through Late-Stage Clinical Development
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Arrakis Therapeutics Announces $75 Million Series B Financing to Advance a New Class of Small-Molecule Medicines Targeting RNA
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.